Bicycle Therapeutics (BCYC) Invested Capital (2024)

Bicycle Therapeutics (BCYC) posted Invested Capital of $22.4 million for Q2 2024.

Bicycle Therapeutics (BCYC) Invested Capital (2024) Analysis & Trends

Bicycle Therapeutics' Invested Capital history runs 1 years deep, the most recent figure standing at $22.4 million for Q2 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - 110.96 Mn
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 116.14 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Bicycle Therapeutics 289.88 Mn 289.88 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2024 22.40 Mn